10-K.Info (Beta Test) Courtesy of Short Sands, LLC | ||||||||||||||
| ||||||||||||||
|
10-K.Info (Beta Test) Courtesy of Short Sands, LLC | ||
ABBOTT LABORATORIES | ||
Ticker: ABT Fiscal Year: 2014 | ||
Consolidated Balance Sheet | ||
Period Ending Dec 31, 2014 10-K (Filed: Feb 27, 2015) | ||
(In Millions, except shares in actual) | ||
As of | As of | |
Dec 31, 2014 | Dec 31, 2013 | |
Assets | ||
Current Assets: | ||
Cash and cash equivalents | $ 4,063 | 3,475 |
Investments, primarily bank time deposits and U.S. treasury bills | 397 | 4,623 |
Trade receivables, less allowances of - 2014: $310; 2013: $312 | 3,586 | 3,986 |
Inventories: | ||
Finished products | 1,807 | 1,866 |
Work in process | 278 | 349 |
Materials | 558 | 478 |
Total inventories | 2,643 | 2,693 |
Deferred income taxes | 1,705 | 2,528 |
Other prepaid expenses and receivables | 1,975 | 1,504 |
Current assets held for disposition | 892 | 438 |
Total Current Assets | 15,261 | 19,247 |
Investments | 229 | 119 |
Property and Equipment, at Cost: | ||
Land | 457 | 502 |
Buildings | 2,968 | 2,994 |
Equipment | 8,480 | 8,506 |
Construction in progress | 727 | 868 |
Property and Equipment, at cost | 12,632 | 12,870 |
Less: accumulated depreciation and amortization | 6,697 | 6,965 |
Net property and equipment | 5,935 | 5,905 |
Intangible assets, net of amortization | 6,198 | 5,735 |
Goodwill | 10,067 | 9,772 |
Deferred income taxes and other assets | 1,651 | 2,109 |
Non-current assets held for disposition | 1,934 | 66 |
Total Assets | 41,275 | 42,953 |
Liabilities and Shareholders' Investment | ||
Current Liabilities: | ||
Short-term borrowings | 4,382 | 3,164 |
Trade accounts payable | 1,064 | 1,026 |
Salaries, wages and commissions | 776 | 906 |
Other accrued liabilities | 2,943 | 3,500 |
Dividends payable | 362 | 341 |
Income taxes payable | 270 | 175 |
Current portion of long-term debt | 55 | 9 |
Current liabilities held for disposition | 680 | 386 |
Total Current Liabilities | 10,532 | 9,507 |
Long-term debt | 3,408 | 3,388 |
Post-employment Obligations and other long - term Liabilities | 5,588 | 4,784 |
Non-current liabilities held for disposition | 108 | 7 |
Commitments and Contingencies | ||
Shareholders' Investment: | ||
Preferred shares, one dollar par value Authorized - 1,000,000 shares, none issued | ||
Common shares, without par value Authorized - 2,400,000,000 shares Issued at stated capital amount - Shares: 2014: 1,694,929,949; 2013: 1,685,827,096 | 12,383 | 12,048 |
Common shares held in treasury, at cost - Shares: 2014: 186,894,515; 2013: 137,728,810 | (8,678) | (6,844) |
Earnings employed in the business | 22,874 | 21,979 |
Accumulated other comprehensive income (loss) | (5,053) | (2,012) |
Total Abbott Shareholders' Investment | 21,526 | 25,171 |
Noncontrolling Interests in Subsidiaries | 113 | 96 |
Total Shareholders' Investment | 21,639 | 25,267 |
Total Liabilities and Shareholders' Investment | 41,275 | 42,953 |
External Links | |
ABBOTT LABORATORIES (ABT) Fiscal Year 2014 | |
Statements of 10-K in Excel | https://www.sec.gov/.../Financial.xlxs |
Complete 10-K in HTML | https://www.sec.gov/.../10-K.html |
Complete 10-K in XBRL | https://www.sec.gov/.../10-K-xbrl.zip |